Miyuki Kubota
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Miyuki Kubota has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Kazuno Negishi
Department of Ophthalmology, Keio University School of Medicine, Tokyo 160-8582, Japan
2 shared publications - Kazuo Tsubota
Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan; and
2 shared publications - Masahiko Ayaki
Department of Ophthalmology, Keio University School of Medicine, Tokyo 160-8582, Japan
2 shared publications - Shunsuke Kubota
Laboratory of Retinal Cell Biology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
2 shared publications Abdoulaye Sene
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA
1 shared publicationAndrea Santeford
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA
1 shared publication
Latest Publications
- Open Access
- 18 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 9049
Reduced Luminance Impairs Near Visual Acuity Despite Preserved Distance Visual Acuity in Presbyopic-Age Adults, with Distinct Pupillary Responses
Background/Objectives: Near-vision difficulties associated with presbyopia may become apparent under reduced luminance despite preserved distance visual acuity. We compared near visual function and pupillary responses between younger and presbyopic-age adults under photopic and reduced-luminance (RL) conditions. Methods: This prospective cross-sectional study included 21 younger adults aged 20–35 years and 21 presbyopic-age adults aged 40–55 years. Corrected distance visual acuity (CDVA), distance-corrected near visual acuity (DCNVA), corrected near visual acuity (CNVA), accommodative amplitude, pupil area, and pupil constriction rate were assessed under photopic and RL conditions. RL conditions were produced using a neutral-density 0.9 filter (chart luminance, 9.63 cd/m2). Results: CDVA did not differ significantly between groups under either condition. DCNVA and CNVA were worse in the presbyopic-age group under both conditions (all p < 0.05), and the declines in both measures from photopic to RL conditions were greater in this group (both p < 0.01). Increasing the near add power improved CNVA under RL conditions in the presbyopic-age group, although CNVA remained worse than under photopic conditions (p = 0.003). In the younger group, CNVA under RL conditions with the RL near add power did not differ significantly from photopic CNVA. Pupil constriction rates were higher in the presbyopic-age group under both photopic (p < 0.05) and RL (p < 0.001) conditions. Under RL conditions, mean pupil area was larger during near viewing than during distance viewing in the younger group, whereas the opposite pattern was observed in the presbyopic-age group. Conclusions: Under RL conditions, the decline in near visual acuity was greater in presbyopic-age participants than in younger participants, despite preserved distance visual acuity. Pupillary responses differed between the groups, but their relationship with near visual deterioration remains to be established. Further studies are needed to determine whether near visual assessment under RL conditions provides additional clinical value.
- 18 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 9049
Open AccessReduced Luminance Impairs Near Visual Acuity Despite Preserved Distance Visual Acuity in Presbyopic-Age Adults, with Distinct Pupillary Responses
Background/Objectives: Near-vision difficulties associated with presbyopia may become apparent under reduced luminance despite preserved distance visual acuity. We compared near visual function and pupillary responses between younger and presbyopic-age adults under photopic and reduced-luminance (RL) conditions. Methods: This prospective cross-sectional study included 21 younger adults aged 20–35 years and 21 presbyopic-age adults aged 40–55 years. Corrected distance visual acuity (CDVA), distance-corrected near visual acuity (DCNVA), corrected near visual acuity (CNVA), accommodative amplitude, pupil area, and pupil constriction rate were assessed under photopic and RL conditions. RL conditions were produced using a neutral-density 0.9 filter (chart luminance, 9.63 cd/m2). Results: CDVA did not differ significantly between groups under either condition. DCNVA and CNVA were worse in the presbyopic-age group under both conditions (all p < 0.05), and the declines in both measures from photopic to RL conditions were greater in this group (both p < 0.01). Increasing the near add power improved CNVA under RL conditions in the presbyopic-age group, although CNVA remained worse than under photopic conditions (p = 0.003). In the younger group, CNVA under RL conditions with the RL near add power did not differ significantly from photopic CNVA. Pupil constriction rates were higher in the presbyopic-age group under both photopic (p < 0.05) and RL (p < 0.001) conditions. Under RL conditions, mean pupil area was larger during near viewing than during distance viewing in the younger group, whereas the opposite pattern was observed in the presbyopic-age group. Conclusions: Under RL conditions, the decline in near visual acuity was greater in presbyopic-age participants than in younger participants, despite preserved distance visual acuity. Pupillary responses differed between the groups, but their relationship with near visual deterioration remains to be established. Further studies are needed to determine whether near visual assessment under RL conditions provides additional clinical value.
- Open Access
- 19 March 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
Randomized, crossover clinical efficacy trial in humans and mice on tear secretion promotion and lacrimal gland protection by molecular hydrogen
The incidence of dry eye disease is increasing worldwide because of the aging population and increasing use of information technology. Dry eye disease manifests as tear-layer instability and inflammation caused by osmotic hypersensitization in tear fluids; however, to our knowledge, no agent that treats both pathologies simultaneously is available. Molecular hydrogen (H2) is known to be effective against various diseases; therefore, we aimed to elucidate the effects of H2 on tear dynamics and the treatment of dry eye disease. We revealed that administering a persistent H2-generating supplement increased the human exhaled H2 concentration (p < 0.01) and improved tear stability (p < 0.01) and dry eye symptoms (p < 0.05) significantly. Furthermore, H2 significantly increased tear secretion in healthy mice (p < 0.05) and significantly suppressed tear reduction in a murine dry eye model (p = 0.007). H2 significantly and safely improved tear stability and dry eye symptoms in a small exploratory group of 10 human subjects, a subset of whom reported dry eye symptoms prior to treatment. Furthermore, it increased tear secretion rapidly in normal mice. Therefore, H2 may be a safe and effective new treatment for dry eye disease and thus larger trials are warranted.
- 19 March 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
Open AccessRandomized, crossover clinical efficacy trial in humans and mice on tear secretion promotion and lacrimal gland protection by molecular hydrogen
The incidence of dry eye disease is increasing worldwide because of the aging population and increasing use of information technology. Dry eye disease manifests as tear-layer instability and inflammation caused by osmotic hypersensitization in tear fluids; however, to our knowledge, no agent that treats both pathologies simultaneously is available. Molecular hydrogen (H2) is known to be effective against various diseases; therefore, we aimed to elucidate the effects of H2 on tear dynamics and the treatment of dry eye disease. We revealed that administering a persistent H2-generating supplement increased the human exhaled H2 concentration (p < 0.01) and improved tear stability (p < 0.01) and dry eye symptoms (p < 0.05) significantly. Furthermore, H2 significantly increased tear secretion in healthy mice (p < 0.05) and significantly suppressed tear reduction in a murine dry eye model (p = 0.007). H2 significantly and safely improved tear stability and dry eye symptoms in a small exploratory group of 10 human subjects, a subset of whom reported dry eye symptoms prior to treatment. Furthermore, it increased tear secretion rapidly in normal mice. Therefore, H2 may be a safe and effective new treatment for dry eye disease and thus larger trials are warranted.
- Open Access
- 18 August 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (8) , 2678
Difference in Pupillary Diameter as an Important Factor for Evaluating Amplitude of Accommodation: A Prospective Observational Study
Presbyopia is increasing globally due to aging and the widespread use of visual display terminals. Presbyopia is a decrease in the eye’s amplitude of accommodation (AA) due to loss of crystalline lens elasticity. AA differs widely among individuals. We aimed to determine the factors that cause presbyopia, other than advanced age, for early medical intervention. We examined 95 eyes of 95 healthy volunteers (33 men, 62 women) aged 22–62 years (mean: 37.22 ± 9.77 years) with a corrected visual acuity of ≥1.0 and without other eye afflictions except ametropia. Subjective refraction, AA, maximum and minimum pupillary diameters during accommodation, axial length of the eye, and crystalline lens thickness were measured. AA was measured using an auto refractometer/keratometer/tonometer/pachymeter. The difference between maximum and minimum pupillary diameters was calculated. On multiple regression analysis, age and difference in pupillary diameter were both significantly and independently associated with AA in participants aged <44 years, but not in those aged ≥45 years. Our results suggest that the difference in pupillary diameter could be an important age-independent factor for evaluating AA in healthy individuals without cataract. Thus, improving the difference in pupillary diameter values could be an early treatment target for presbyopia.
- 18 August 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (8) , 2678
Open AccessDifference in Pupillary Diameter as an Important Factor for Evaluating Amplitude of Accommodation: A Prospective Observational Study
Presbyopia is increasing globally due to aging and the widespread use of visual display terminals. Presbyopia is a decrease in the eye’s amplitude of accommodation (AA) due to loss of crystalline lens elasticity. AA differs widely among individuals. We aimed to determine the factors that cause presbyopia, other than advanced age, for early medical intervention. We examined 95 eyes of 95 healthy volunteers (33 men, 62 women) aged 22–62 years (mean: 37.22 ± 9.77 years) with a corrected visual acuity of ≥1.0 and without other eye afflictions except ametropia. Subjective refraction, AA, maximum and minimum pupillary diameters during accommodation, axial length of the eye, and crystalline lens thickness were measured. AA was measured using an auto refractometer/keratometer/tonometer/pachymeter. The difference between maximum and minimum pupillary diameters was calculated. On multiple regression analysis, age and difference in pupillary diameter were both significantly and independently associated with AA in participants aged <44 years, but not in those aged ≥45 years. Our results suggest that the difference in pupillary diameter could be an important age-independent factor for evaluating AA in healthy individuals without cataract. Thus, improving the difference in pupillary diameter values could be an early treatment target for presbyopia.
- Open Access
- 1 September 2016
- Published by Elsevier in Cell Reports
- Vol. 17 (1) , 69-85
NAMPT-Mediated NAD+ Biosynthesis Is Essential for Vision In Mice
- 1 September 2016
- Published by Elsevier in Cell Reports
- Vol. 17 (1) , 69-85
Open AccessNAMPT-Mediated NAD+ Biosynthesis Is Essential for Vision In Mice
- 10 December 2008
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 47 (1) , 70-74
Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients
The stable fractions of glycated hemoglobin (Hb), particularly HbA(1c), and glycated albumin (GA) were measured to monitor chronic glycemic control. Haptoglobin (Hp) is a Hb-binding protein, which plays a major role in preventing free Hb-induced tissue oxidative damage. The aim of this study was to clarify the relationships of serum Hp concentration with HbA(1c) and GA concentrations. A cross-sectional study to determine the relationship of serum Hp concentration with GA and HbA(1c) concentrations was conducted. The subjects were 125 Japanese type 2 diabetic patients with stable HbA(1c) levels for more than 3 consecutive months. Patients with altered albumin and red blood cell turnover, which are observed in those with chronic renal failure, liver cirrhosis, and anemia among others, were excluded from the study. Serum Hp concentration positively correlated with HbA(1c) concentration (r=0.30, p<0.001), but not with GA concentration (r=0.15, p=0.10). There was a weak inverse correlation between serum Hp concentration and GA/HbA(1c) ratio (r=-0.19, p=0.03). Moreover, GA /HbA(1c) ratio inversely correlated with body mass index (BMI) (r=-0.31, p<0.001). In contrast, there was no significant correlation between Hb concentration and HbA(1c) (r=0.01, p=0.88) or GA (r=0.12, p=0.21) concentrations. We also analyzed the correlation of serum Hp concentration with GA and HbA(1c) concentrations in patients with the Hp 2-1 and Hp 2-2 genotypes, separately. Hp concentration positively correlated with HbA(1c) concentration in patients with the Hp 2-1 (r=0.32, p=0.03) and Hp 2-2 (r=0.29, p=0.02) phenotypes. Multiple regression analysis revealed that the observed correlation between Hp and HbA(1c) concentrations was significant after adjustment for age, gender, and BMI. In contrast, there was no significant correlation between GA and Hp concentrations in patients with either phenotype. Then, we analyzed how Hp concentration affects GA/HbA(1c) ratio in patients with these Hp phenotypes. There was an inverse correlation between Hp concentration and GA/HbA(1c) ratio in patients with Hp 2-1 (r=-0.44, p=0.003), but not in those with Hp 2-2 (r=-0.03, p=0.75). Multiple regression analysis revealed that the inverse correlation between Hp concentration and GA/HbA(1c) ratio in patients with Hp 2-1 was independent of age, gender, and BMI. Hp phenotype and concentration should be considered in interpreting HbA(1c) and GA levels as glycemic control indicators in diabetic patients. We suggest that in type 2 diabetic patients with Hp 2-1 and high Hp concentrations, HbA(1c) level may be overestimated relative to GA level.
- 10 December 2008
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 47 (1) , 70-74
Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients
The stable fractions of glycated hemoglobin (Hb), particularly HbA(1c), and glycated albumin (GA) were measured to monitor chronic glycemic control. Haptoglobin (Hp) is a Hb-binding protein, which plays a major role in preventing free Hb-induced tissue oxidative damage. The aim of this study was to clarify the relationships of serum Hp concentration with HbA(1c) and GA concentrations. A cross-sectional study to determine the relationship of serum Hp concentration with GA and HbA(1c) concentrations was conducted. The subjects were 125 Japanese type 2 diabetic patients with stable HbA(1c) levels for more than 3 consecutive months. Patients with altered albumin and red blood cell turnover, which are observed in those with chronic renal failure, liver cirrhosis, and anemia among others, were excluded from the study. Serum Hp concentration positively correlated with HbA(1c) concentration (r=0.30, p<0.001), but not with GA concentration (r=0.15, p=0.10). There was a weak inverse correlation between serum Hp concentration and GA/HbA(1c) ratio (r=-0.19, p=0.03). Moreover, GA /HbA(1c) ratio inversely correlated with body mass index (BMI) (r=-0.31, p<0.001). In contrast, there was no significant correlation between Hb concentration and HbA(1c) (r=0.01, p=0.88) or GA (r=0.12, p=0.21) concentrations. We also analyzed the correlation of serum Hp concentration with GA and HbA(1c) concentrations in patients with the Hp 2-1 and Hp 2-2 genotypes, separately. Hp concentration positively correlated with HbA(1c) concentration in patients with the Hp 2-1 (r=0.32, p=0.03) and Hp 2-2 (r=0.29, p=0.02) phenotypes. Multiple regression analysis revealed that the observed correlation between Hp and HbA(1c) concentrations was significant after adjustment for age, gender, and BMI. In contrast, there was no significant correlation between GA and Hp concentrations in patients with either phenotype. Then, we analyzed how Hp concentration affects GA/HbA(1c) ratio in patients with these Hp phenotypes. There was an inverse correlation between Hp concentration and GA/HbA(1c) ratio in patients with Hp 2-1 (r=-0.44, p=0.003), but not in those with Hp 2-2 (r=-0.03, p=0.75). Multiple regression analysis revealed that the inverse correlation between Hp concentration and GA/HbA(1c) ratio in patients with Hp 2-1 was independent of age, gender, and BMI. Hp phenotype and concentration should be considered in interpreting HbA(1c) and GA levels as glycemic control indicators in diabetic patients. We suggest that in type 2 diabetic patients with Hp 2-1 and high Hp concentrations, HbA(1c) level may be overestimated relative to GA level.